JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GTLS
2576
DELISTED
Chart Industries
GTLS
| $4.9M | ﹤0.01% |
104,543
+69,578
| +199% | +$3.11M |
2013 Q2
18 quarters
|
|
|
BCPC
2577
Balchem Corp
BCPC
$5.31B
| $4.89M | ﹤0.01% |
60,709
-11,445
| -16% | -$953K |
2015 Q2
10 quarters
|
|
2578
Colliers International
CIGI
$4.62B
| $4.89M | ﹤0.01% |
81,067
+25,689
| +46% | +$1.48M |
2017 Q1
3 quarters
|
|
|
CIVI
2579
DELISTED
Civitas Resources
CIVI
| $4.88M | ﹤0.01% |
177,058
-367,058
| -67% | -$11.5M |
2017 Q2
2 quarters
|
|
2580
CALL
Upbound Group
UPBD
$946M
| $4.88M | ﹤0.01% |
+440,000
| New | +$4.82M |
2017 Q4
0 quarters
|
|
2581
NBT Bancorp
NBTB
$2.66B
| $4.88M | ﹤0.01% |
132,652
+33,918
| +34% | +$1.28M |
2013 Q2
18 quarters
|
|
|
DBD
2582
DELISTED
Diebold Nixdorf Incorporated
DBD
| $4.87M | ﹤0.01% |
298,069
+265,280
| +809% | +$5.13M |
2013 Q2
18 quarters
|
|
2583
SPX Corp
SPXC
$8.67B
| $4.87M | ﹤0.01% |
155,143
+17,230
| +12% | +$523K |
2013 Q2
18 quarters
|
|
|
SJI
2584
DELISTED
South Jersey Industries, Inc.
SJI
| $4.86M | ﹤0.01% |
155,698
+129,714
| +499% | +$4.29M |
2016 Q4
4 quarters
|
|
2585
Ryman Hospitality Properties
RHP
$8.37B
| $4.85M | ﹤0.01% |
70,232
+58,793
| +514% | +$3.93M |
2015 Q3
9 quarters
|
|
2586
Southern Copper
SCCO
$172B
| $4.84M | ﹤0.01% |
111,308
-97,619
| -47% | -$3.88M |
2013 Q2
18 quarters
|
|
|
TLP
2587
DELISTED
Transmontaigne
TLP
| $4.83M | ﹤0.01% |
122,476
+47,818
| +64% | +$1.96M |
2013 Q2
18 quarters
|
|
2588
MGE Energy Inc
MGEE
$2.67B
| $4.83M | ﹤0.01% |
76,554
+11,091
| +17% | +$721K |
2013 Q2
18 quarters
|
|
2589
LGI Homes
LGIH
$1.11B
| $4.83M | ﹤0.01% |
64,326
-2,581
| -4% | -$164K |
2015 Q3
9 quarters
|
|
2590
FerroAtlántica
GSM
$800M
| $4.82M | ﹤0.01% |
297,567
+66,015
| +29% | +$1.02M |
2016 Q4
4 quarters
|
|
|
ALDR
2591
DELISTED
Alder Biopharmaceuticals
ALDR
| $4.82M | ﹤0.01% |
420,605
+905
| +0.2% | +$10.1K |
2015 Q3
9 quarters
|
|
|
BHR
2592
Braemar Hotels & Resorts
BHR
$114M
| $4.82M | ﹤0.01% |
499,785
+1,072
| +0.2% | +$10.2K |
2013 Q4
16 quarters
|
|
|
BLUE
2593
CALL
DELISTED
bluebird bio
BLUE
| $4.81M | ﹤0.01% |
+2,084
| New | +$4.23M |
2017 Q4
0 quarters
|
|
|
BLUE
2594
PUT
DELISTED
bluebird bio
BLUE
| $4.81M | ﹤0.01% |
+2,084
| New | +$4.23M |
2017 Q4
0 quarters
|
|
2595
iShares Latin America 40 ETF
ILF
$3.85B
| $4.8M | ﹤0.01% |
140,543
-33,789
| -19% | -$1.15M |
2013 Q2
18 quarters
|
|
2596
The Ensign Group
ENSG
$10B
| $4.8M | ﹤0.01% |
231,165
+83,017
| +56% | +$1.78M |
2013 Q2
18 quarters
|
|
2597
CALL
iShares Silver Trust
SLV
$29.3B
| $4.8M | ﹤0.01% |
300,000
| – | – |
2016 Q3
5 quarters
|
|
|
ENDP
2598
DELISTED
Endo International plc
ENDP
| $4.79M | ﹤0.01% |
618,803
+388,053
| +168% | +$2.9M |
2013 Q2
18 quarters
|
|
2599
Apogee Enterprises
APOG
$743M
| $4.78M | ﹤0.01% |
104,630
-14,510
| -12% | -$692K |
2015 Q3
9 quarters
|
|
2600
Ingles Markets
IMKTA
$1.63B
| $4.78M | ﹤0.01% |
138,117
+21,242
| +18% | +$578K |
2015 Q1
11 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.